Does TICAGRELOR Cause Prostatic specific antigen increased? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Prostatic specific antigen increased have been filed in association with TICAGRELOR (Ticagrelor). This represents 0.1% of all adverse event reports for TICAGRELOR.
13
Reports of Prostatic specific antigen increased with TICAGRELOR
0.1%
of all TICAGRELOR reports
0
Deaths
5
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From TICAGRELOR?
Of the 13 reports, 5 (38.5%) required hospitalization.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TICAGRELOR. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does TICAGRELOR Cause?
Dyspnoea (3,156)
Myocardial infarction (1,749)
Death (1,510)
Off label use (1,084)
Fatigue (1,081)
Chest pain (1,075)
Contusion (970)
Dizziness (811)
Vascular stent thrombosis (700)
Haemorrhage (676)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
ABIRATERONE (1,581)
RADIUM RA-223 DICHLORIDE (449)
RELUGOLIX (335)
BICALUTAMIDE (322)
DOCETAXEL (282)
APALUTAMIDE (251)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
Which TICAGRELOR Alternatives Have Lower Prostatic specific antigen increased Risk?
TICAGRELOR vs TICLOPIDINE
TICAGRELOR vs TIGECYCLINE
TICAGRELOR vs TIKOSYN
TICAGRELOR vs TILDRAKIZUMAB
TICAGRELOR vs TILDRAKIZUMAB-ASMN